Showing results (31-40 of 95) with videos related to
Sort By:
Pageof 10
BMC Cancer|October 18, 2012
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphomaEgil S Blix, Jonathan M Irish, Anne Husebekk, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 30, 2017
Biodistribution and Dosimetry Results from a Phase 1 Trial of Therapy with the Antibody-Radionuclide Conjugate <sup>177</sup>Lu-Lilotomab SatetraxetanJohan Blakkisrud, Jon Erik Holtedahl, Ayca Løndalen, et al.Immunology|June 10, 2016
Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosisKristine L Holm, Randi L Indrevaer, June Helen Myklebust, et al.Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|March 5, 2025
Allogeneic stem cell transplantation for patients with lymphoma 2011-21Hege Melby Frøen, Marianne Brodtkorb, Harald Holte, et al.Anticancer Research|December 26, 2012
Evaluating antigen targeting and anti-tumor activity of a new anti-CD37 radioimmunoconjugate against non-Hodgkin's lymphomaJostein Dahle, Ada H V Repetto-Llamazares, Camilla S Mollatt, et al.Hematological Oncology|October 29, 2021
Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experienceÅsa Lindberg, Christian Winther Eskelund, Alexandra Albertsson-Lindblad, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 6, 2016
Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab SatetraxetanJohan Blakkisrud, Ayca Løndalen, Anne C T Martinsen, et al.Cancer Reports (Hoboken, N.J.)|July 28, 2021
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphomaLavanya Lokhande, Venera Kuci Emruli, Christian Winther Eskelund, et al.International Journal of Cancer|June 2, 2011
T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cellsIngerid Weum Abrahamsen, Synneva Kjellevoll, Margrethe Greve-Isdahl, et al.The New England Journal of Medicine|February 4, 2005
131I-tositumomab therapy as initial treatment for follicular lymphomaMark S Kaminski, Melissa Tuck, Judith Estes, et al.Pageof 10